The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease
Status:
Not yet recruiting
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
ASTED (Antioxidant Supplements for TED) trial is an investigator-initiated, randomized,
triple masked, clinical trial of a selected combination of vitamins and minerals versus
placebo in patients with moderate to severe thyroid eye disease. The trial has a parallel-arm
design.